Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 25 September 2026 (Including F&O)

  • September 24, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow, 25 September 2026 (Including F&O)

Nifty Pharma closed at 27,028.70, down 0.45% today. Nifty 50 fell 1.64%. India VIX spiked 22.8%.

Quick Answer

The nifty pharma prediction for tomorrow is cautious for 25 September 2026, with Apollo Hospitals Enterprise as the key constituent to track, tracking broader Nifty 50 direction and F&O positioning into Friday’s session.

As with any nifty pharma prediction for tomorrow, the opening minutes of trade will confirm or challenge the levels discussed here.

The nifty pharma prediction for tomorrow is in focus after a Thursday session in which the broader Nifty 50 fell 1.64 percent to 23,063.10, as India VIX spiked 22.8 percent to a much higher 12.71, as rising US Treasury yields, firm crude oil prices and IRDAI’s proposed insurance distribution commission cap hit banking and financial stocks hard, with Nifty Private Bank the weakest major sector. Pharma stocks held up relatively well today, among the more resilient sectors even as apollo hospitals itself eased more sharply

This nifty pharma prediction for tomorrow is built from Thursday’s verified closing data, not speculation about what Friday will bring.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are watching sector-specific triggers here, alongside the broader Nifty 50 and Sensex direction heading into 25 September 2026.

Click Here – Get Free Investment Predictions

Nothing in this nifty pharma prediction for tomorrow should be treated as a guarantee, only a working framework for Friday’s session.

Also read – Stock Market Predictions for Tomorrow, 25 September 2026

Table of Contents

Toggle
  • Today’s Sector Recap
  • Nifty Pharma F&O Outlook for Tomorrow
  • Key Drivers for Tomorrow
  • Stocks to Watch for Tomorrow
  • Risks to This Prediction
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow?
    • Which stocks matter most for this sector’s outlook tomorrow?
    • Did Nifty Pharma hold up better than the broader market today?
    • Should traders take F&O positions based on this outlook?

Today’s Sector Recap

  • Apollo Hospitals Enterprise fell 1.99 percent, among the key movers in this space on 24 September 2026.
  • The broader Nifty 50 fell 1.64 percent, setting a cautious tone across most sectors.
  • India VIX spiked 22.8 percent, its sharpest single-day jump this month.

This nifty pharma prediction for tomorrow should be read alongside the support and resistance levels detailed above.

Nifty Pharma F&O Outlook for Tomorrow

For traders active in F&O, this outlook will hinge on open interest build-up and rollover activity in Nifty Pharma futures and options contracts into 25 September 2026. Kunal Singla notes that a stable to falling India VIX would support range-bound F&O positioning, while continued volatility could see wider intraday swings.

Key Drivers for Tomorrow

  • Pharma stocks held up relatively well today, among the more resilient sectors even as apollo hospitals itself eased more sharply
  • Crude oil rose sharply, up 1.65 percent on mcx, tracking the same global pressures that hit equities, as rising bond yields and firm oil prices moved together, a theme relevant across the broader market.
  • India vix spiked 22.8 percent to a much higher 12.71, as rising us treasury yields, firm crude oil prices and irdai’s proposed insurance distribution commission cap hit banking and financial stocks hard, with nifty private bank the weakest major sector.

Univest’s desk will revisit this nifty pharma prediction for tomorrow once Friday’s opening trade confirms direction.

Stocks to Watch for Tomorrow

Stock CMP Relevance
Apollo Hospitals Enterprise See Univest Screener Key Nifty Pharma constituent

Explore Nifty Pharma Stocks on Univest Screeners

Traders relying on this nifty pharma prediction for tomorrow should still size positions to their own risk appetite.

Risks to This Prediction

  • A sharper than expected move in crude oil prices or US bond yields could shift sentiment across all sectors, including Nifty Pharma.
  • Stock-specific news flow in Apollo Hospitals Enterprise or other constituents could override the broader sector trend.
  • A further rise in India VIX could widen intraday ranges beyond the levels discussed here.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces.

As with any nifty pharma prediction for tomorrow, the opening minutes of trade will confirm or challenge the levels discussed here.

Conclusion

The nifty pharma prediction for tomorrow leans cautious into 25 September 2026, with Apollo Hospitals Enterprise and broader Nifty 50 direction as the key variables. Ankit Jaiswal and Kunal Singla will revisit this view once Friday’s opening trade confirms direction.

Also read – Nifty 50 Prediction for Tomorrow, 25 September 2026

This nifty pharma prediction for tomorrow is built from Thursday’s verified closing data, not speculation about what Friday will bring.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is cautious, based on Apollo Hospitals Enterprise’s fall of 1.99 percent on 24 September 2026 and the broader Nifty 50 trend.

Which stocks matter most for this sector’s outlook tomorrow?

Ans. Apollo Hospitals Enterprise is one of the key stocks to track, along with the broader Nifty 50 and Sensex direction.

Did Nifty Pharma hold up better than the broader market today?

Ans. Nifty Pharma held up notably better than the broader market today, down just 0.45 percent versus the Nifty 50’s sharper 1.64 percent fall.

Should traders take F&O positions based on this outlook?

Ans. Any F&O position based on this outlook should factor in position sizing and stop-loss discipline, given how sharply India VIX has moved this week.



Nifty Pharma
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply